secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2024-08-19T23:59:59+00:00
Accession:  0001493152-24-033119
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics sets 2024 annual meeting for Sept 27; proposal deadline Aug 29
--------------------------------------------------------------------------------

- Annual meeting scheduled for September 27, 2024.
- Stockholder proposals and nominations must be received by August 29, 2024.
- Date is >30 days from 2023 annual meeting anniversary, triggering special notice timeline.
- All notices must be directed to company's principal executive offices per bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000149315224033119/0001493152-24-033119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000149315224033119/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer